PeptiDream Inc (PPTDF)
17.00
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
PeptiDream Cash from Financing (Quarterly): -4.424M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -4.424M |
| March 31, 2024 | -5.103M |
| December 31, 2023 | 22.30M |
| September 30, 2023 | -3.639M |
| June 30, 2023 | -8.142M |
| March 31, 2023 | -8.634M |
| December 31, 2022 | 7.953M |
| September 30, 2022 | -14.89M |
| June 30, 2022 | -24.61M |
| March 31, 2022 | 190.98M |
| December 31, 2021 | 0.1971M |
| September 30, 2021 | -0.0023M |
| June 30, 2021 | 0.221M |
| March 31, 2021 | 0.1863M |
| December 31, 2020 | 0.0105M |
| September 30, 2020 | -0.0307M |
| June 30, 2020 | -2.263M |
| March 31, 2020 | 0.0603M |
| September 30, 2019 | |
| June 30, 2019 | 0.1176M |
| March 31, 2019 | 0.0606M |
| December 31, 2018 | -0.0028M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.0812M |
| June 30, 2018 | -0.038M |
| March 31, 2018 | 1.048M |
| December 31, 2017 | -0.0097M |
| September 30, 2017 | 0.5444M |
| June 30, 2017 | 0.0178M |
| March 31, 2017 | 0.7962M |
| December 31, 2016 | -3.52M |
| September 30, 2016 | 3.125M |
| June 30, 2016 | 5.655M |
| March 31, 2016 | 9.298M |
| December 31, 2015 | -0.0002M |
| September 30, 2015 | 0.0098M |
| June 30, 2015 | 0.0159M |
| March 31, 2015 | 0.0942M |
| December 31, 2014 | -0.0093M |
| September 30, 2014 | 0.2878M |
| June 30, 2014 | 0.0149M |
| March 31, 2014 | -0.004M |
| December 31, 2013 | 0.0473M |
| September 30, 2013 | 0.1236M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-24.61M
Minimum
Jun 2022
190.98M
Maximum
Mar 2022
8.342M
Average
-0.0165M
Median
Cash from Financing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 2.030B |
| Nxera Pharma Co Ltd | -10.15M |
| Healios KK | 8.664M |
| AnGes Inc | -- |
| SanBio Co Ltd | 2.166M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.106M |
| Cash from Investing (Quarterly) | -6.172M |
| Free Cash Flow | -4.265M |
| Free Cash Flow Per Share (Quarterly) | -0.0529 |
| Free Cash Flow to Equity (Quarterly) | 5.631M |
| Free Cash Flow to Firm (Quarterly) | -6.865M |
| Free Cash Flow Yield | -0.19% |